P

Inventor

HEARTLEIN MICHAEL W

US29 patents
⚠️ This page may combine multiple inventors who share the name “HEARTLEIN MICHAEL W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TRANSKARYOTIC THERAPIES INC

26 patents
US5733761AMar 31, 1998

Protein production and protein delivery

TRANSKARYOTIC THERAPIES INC317 citations99
US5641670AJun 24, 1997

Protein production and protein delivery

TRANSKARYOTIC THERAPIES INC502 citations99
US6670178B1Dec 30, 2003

In Vivo production and delivery of insulinotropin for gene therapy

TRANSKARYOTIC THERAPIES INC105 citations98
US6063630AMay 16, 2000

Targeted introduction of DNA into primary or secondary cells and their use for gene therapy

TRANSKARYOTIC THERAPIES INC93 citations98
US5968502AOct 19, 1999

Protein production and protein delivery

TRANSKARYOTIC THERAPIES INC91 citations98
US5817789AOct 6, 1998

Chimeric proteins for use in transport of a selected substance into cells

TRANSKARYOTIC THERAPIES INC99 citations98
US5994127ANov 30, 1999

In vivo production and delivery of erythropoietin or insulinotropin for gene therapy

TRANSKARYOTIC THERAPIES INC78 citations97
US6187305B1Feb 13, 2001

Targeted introduction of DNA into primary or secondary cells and their use for gene therapy and protein production

TRANSKARYOTIC THERAPIES INC43 citations96
US6048524AApr 11, 2000

In vivo production and delivery of erythropoietin for gene therapy

TRANSKARYOTIC THERAPIES INC42 citations96
US6048729AApr 11, 2000

In vivo protein production and delivery system for gene therapy

TRANSKARYOTIC THERAPIES INC74 citations96
US6048724AApr 11, 2000

Method of producing clonal cell strains which express exogenous DNA encoding glucagon-like peptide 1

TRANSKARYOTIC THERAPIES INC42 citations96
US6270989B1Aug 7, 2001

Protein production and delivery

TRANSKARYOTIC THERAPIES INC64 citations95
US6262026B1Jul 17, 2001

Chimeric proteins for use in transport of a selected substance into cells

TRANSKARYOTIC THERAPIES INC52 citations95
US6027921AFeb 22, 2000

Chimeric proteins for use in transport of a selected substance into cells and DNA encoding chimeric proteins

TRANSKARYOTIC THERAPIES INC69 citations95
US6537542B1Mar 25, 2003

Targeted introduction of DNA into primary or secondary cells and their use for gene therapy and protein production

TRANSKARYOTIC THERAPIES INC20 citations92
US6303379B1Oct 16, 2001

Vivo protein production and delivery system for gene therapy

TRANSKARYOTIC THERAPIES INC38 citations92
US6242218B1Jun 5, 2001

Genomic sequences for protein production and delivery

TRANSKARYOTIC THERAPIES INC23 citations92
US6054288AApr 25, 2000

In vivo protein production and delivery system for gene therapy

TRANSKARYOTIC THERAPIES INC43 citations92
US6565844B1May 20, 2003

Protein production and protein delivery

TRANSKARYOTIC THERAPIES INC13 citations84
US6214622B1Apr 10, 2001

Targeted introduction of DNA into primary or secondary cells and their use for gene therapy

TRANSKARYOTIC THERAPIES INC13 citations82
US6846676B2Jan 25, 2005

In Vivo production and delivery of erythropoietin or insulinotropin for gene therapy

TRANSKARYOTIC THERAPIES INC5 citations74
US6692737B1Feb 17, 2004

In vivo protein production and delivery system for gene therapy

TRANSKARYOTIC THERAPIES INC8 citations74
US6355241B1Mar 12, 2002

In vivo production and delivery of erythropoietin

TRANSKARYOTIC THERAPIES INC7 citations74
US6200778B1Mar 13, 2001

Genomic sequences for protein production and delivery

TRANSKARYOTIC THERAPIES INC9 citations74
US6858578B2Feb 22, 2005

Chimeric proteins for use in transport of a selected substance into cells

TRANSKARYOTIC THERAPIES INC10 citations73
US6531124B1Mar 11, 2003

In vivo production and delivery of insulinotropin for gene therapy

TRANSKARYOTIC THERAPIES INC2 citations63

VON FIGURA KURT

1 patent

SHIRE HUMAN GENETIC THERAPIES

1 patent

TAKEDA PHARMACEUTICALS CO

1 patent